- The AI model analyzes medical summaries and tissue samples from the Netherlands Brain Bank to provide insights into brain disease progression and diagnosis challenges.
- It aims to reduce misdiagnoses, which currently affect up to 30% of cases, by identifying molecular markers and contributing to a molecular atlas of brain disease symptoms.
- The model links clinical symptoms with brain tissue data from over 3,000 donors, identifying 90 different symptoms across five domains.
- This research could lead to targeted therapies and more accurate diagnoses during a patient’s lifetime.
The technology holds promise for significantly improving the diagnosis of brain diseases and opening avenues for new treatments1.